Of the 17 CIS genes, 9 show significantdifferential expression when SHH subgroup tumours are compared to all others(including MYT1L and PTEN discussed above), and 15 showdifferential expression in one or more clinicogenetic subgroups(Table 2). This evidence concerns the gene PTEN and neoplasm.